Allergic Conjunctivitis
📧 Sign up to get email alerts when something new happens for Allergic Conjunctivitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2012-03-06Clinical Trial Update: To Evaluate the Efficacy of AL-38583 in the Reduction of Tear Eosinophil Count Following Conjunctival Allergen Challenge [Phase 2]
Phase 2 trial of AL-38583 evaluating reduction of tear eosinophil count after conjunctival allergen challenge has been withdrawn. No efficac…
-
CLINICAL_TRIALS trial_result · 2012-02-07Clinical Trial Update: Twin SUBLIVAC® Grasses Clinical Efficacy Study [Phase 3]
Phase 3 clinical efficacy study of Twin SUBLIVAC Grasses for seasonal allergic rhinitis and allergic conjunctivitis. The study status is com…
-
CLINICAL_TRIALS trial_result · 2012-01-31Clinical Trial Update: Evaluation of the Effect and Tolerance of Preservative Free NAAGA on the Inflammatory Component and Symptoms of Dry Eye Syndrome in Allergic Conjunctivitis Patients [Phase 4]
Phase 4 trial evaluating the effect and tolerance of preservative-free NAAGA on inflammatory components and symptoms of dry eye syndrome in …
-
CLINICAL_TRIALS trial_result · 2011-12-08Clinical Trial Update: Safety and Efficacy Study of a Eye Drop for Eye Allergy [Phase 3]
Phase 3 study evaluating the safety and efficacy of an eye drop for allergic conjunctivitis completed, with trial results posted.
-
FDA approval · 2011-10-31FDA Approved: EPINASTINE HYDROCHLORIDE — Original Application (Somerset Therapeutics, LLC)
The FDA approved Somerset Therapeutics' epinastine hydrochloride as a generic product under an original ANDA for the treatment of allergic c…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-09-27Clinical Trial Update: Evaluation of Efficacy of Ophthalmic Solution in Induced Allergic Conjunctivitis [Phase 3]
Phase 3 clinical trial evaluating the efficacy of an ophthalmic solution for induced allergic conjunctivitis has completed.
-
CLINICAL_TRIALS trial_result · 2011-09-27Clinical Trial Update: Evaluation of Efficacy of Ophthalmic Solution in Induced Acute Allergic Conjunctivitis [Phase 3]
A Phase 3 trial evaluating an ophthalmic solution for induced acute allergic conjunctivitis has completed.
-
CLINICAL_TRIALS trial_result · 2011-07-13Clinical Trial Update: Efficacy-safety Study of Sublingual Immunotherapy With Depigmented-polymerized Pollen Extracts to Treat Rhinoconjunctivitis [Phase 2]
A Phase 2 trial evaluating the efficacy and safety of sublingual immunotherapy with depigmented-polymerized pollen extracts for allergic rhi…
-
CLINICAL_TRIALS trial_result · 2011-07-11Clinical Trial Update: Comparison of Tolerability Between Two Allergy Drops [Phase 4]
This Phase 4 clinical trial update compares tolerability between two allergy eye drop formulations in allergic conjunctivitis.
-
CLINICAL_TRIALS trial_result · 2011-06-20Clinical Trial Update: Glycyphagus Domesticus Allergen Extract. Determination of the in Vivo Biological Activity in Histamine Equivalent Units (HEP). [Phase 2]
Phase 2 trial evaluating the in vivo biological activity of Glycyphagus domesticus allergen extract using histamine equivalent units (HEP) a…
-
CLINICAL_TRIALS trial_result · 2011-04-19Clinical Trial Update: Use of BEPREVE (Bepotastine Besilate Ophthalmic Solution) 1.5% for Allergic Conjunctivitis and Contact Lenses [Phase 4]
Phase 4 clinical trial update on BEPREVE (bepotastine besilate ophthalmic solution) 1.5% for allergic conjunctivitis. The study status is li…
-
FDA approval · 2011-02-15FDA Approved: CETIRIZINE HYDROCHLORIDE — Supplemental Application (Ohm Laboratories Inc.)
FDA approved a supplemental application for cetirizine hydrochloride from Ohm Laboratories, enabling its cetirizine hydrochloride product to…
-
CLINICAL_TRIALS trial_result · 2010-12-17Clinical Trial Update: Immunotherapy With Depigmented and Polymerized Allergen Extract of Phleum Pratense [Phase 2]
Phase 2 trial evaluating depigmented and polymerized Phleum pratense allergen extract for allergic rhinitis, allergic conjunctivitis, and as…
-
FDA approval · 2010-12-08FDA Approved: PATADAY ONCE DAILY RELIEF — Supplemental Application (Alcon Laboratories, Inc.)
The FDA approved a supplemental application for Pataday Once Daily Relief (olopatadine hydrochloride) from Alcon Laboratories, Inc.
-
CLINICAL_TRIALS trial_result · 2010-11-23Clinical Trial Update: Safety Study of a Contact Lens With Ketotifen in Healthy, Normal Volunteers [Phase 3]
Phase 3 safety study of a ketotifen-delivering contact lens in healthy volunteers has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2010-11-23Clinical Trial Update: Safety Study of a Contact Lens With Ketotifen in Healthy, Normal Volunteers [Phase 3]
Phase 3 safety study evaluating a ketotifen-containing contact lens in healthy volunteers to assess tolerability related to allergic conjunc…
-
CLINICAL_TRIALS trial_result · 2010-11-15Clinical Trial Update: Dose Finding Study With CYT003-QbG10 in Patients With House Dust Mite Allergy [Phase 2]
Phase 2 dose-finding trial of CYT003-QbG10 for house dust mite–induced rhinoconjunctivitis has completed.
-
CLINICAL_TRIALS withdrawal · 2010-10-07Clinical Trial Update: Comparison of CL Wear Between Two Allergy Drops [Phase 4]
A phase 4 clinical trial comparing contact lens wear between two allergy eye drops was withdrawn.
-
FDA approval · 2010-09-27FDA Approved: NAPHAZOLINE HCI AND PHENIRAMINE MALEATE — Original Application (Altaire Pharmaceuticals Inc.)
FDA approved Altaire Pharmaceuticals' combination eye drops containing naphazoline hydrochloride and pheniramine maleate under an Original A…
-
CLINICAL_TRIALS trial_result · 2010-08-05Clinical Trial Update: Standardization of Chortoglyphus Arcuatus Allergenic Extract. Determination of Biological Activity in HEP Units [Phase 2]
Phase 2 trial assessing standardization and biological activity of Chortoglyphus Arcuatus Allergenic Extract for allergic rhinitis and aller…
-
FDA approval · 2010-07-28FDA Approved: LASTACAFT — Original Application (Allergan, Inc.)
FDA approved LASTACAFT (alcaftadine) from Allergan in an original application. It is indicated for relief of ocular itching associated with …
-
CLINICAL_TRIALS research · 2010-05-18Clinical Trial Update: The Role of Daily Disposable Contact Lenses in Ocular Allergy [NA]
A completed study investigating the role of daily disposable contact lenses in managing grass pollen–related ocular allergy.
-
CLINICAL_TRIALS trial_result · 2010-05-05Clinical Trial Update: Long-term Efficacy and Safety Study With Oralgen Grass Pollen [Phase 2, Phase 3]
The document announces the completion of a long-term efficacy and safety study (Phase 2/Phase 3) evaluating Oralgen Grass Pollen for allergi…
-
CLINICAL_TRIALS trial_result · 2010-03-15Clinical Trial Update: Efficacy Investigation Study of Olopatadine Hydrochloride Ophthalmic Solution Using OHIO Chamber in Patients With Seasonal Allergic Rhinitis (SAR) [Phase 4]
Phase 4 clinical trial evaluating olopatadine hydrochloride ophthalmic solution in seasonal allergic rhinitis using an OHIO chamber, with re…
-
CLINICAL_TRIALS trial_result · 2009-11-11Clinical Trial Update: Safety Study for Bepotastine Besilate Ophthalmic Solution in Normal Volunteers [Phase 3]
A Phase 3 safety study of Bepotastine Besilate Ophthalmic Solution was completed in normal volunteers, with results posted.